Volume 71, Issue 5_suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Preview this article:
Zoom in


| /docserver/preview/fulltext/14761645/71/5_suppl/0700007-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Ottesen EA, Duke BO, Karam M, Behbehani K, 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75: 491–503. [Google Scholar]
  2. Molyneux DH, Zagaria N, 2002. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 96 (Suppl 2): S15–S40. [Google Scholar]
  3. Campbell WC, 1991. Ivermectin as an antiparasitic agent for use in humans. Annu Rev Microbiol 45: 445–474. [Google Scholar]
  4. Lacey E, 1990. Mode of action of benzimidazoles. Parasitol Today 6: 112–115. [Google Scholar]
  5. Chandasekaran B, Ghirnikar SN, Harinath BC, 1980. Effects of diethylcarbamazine and diethylcarbamazine-N-oxide on microfilariae in vitro in the presence of immune sera and leukocytes. Indian J Exp Biol 18: 1197–1180. [Google Scholar]
  6. King C, Greene B, Spagnuolo P, 1983. Diethylcarbamazine citrate, an antifilarial drug, stimulates human granulocyte adherence. Antimicrob Agents Chemother 24: 453–456. [Google Scholar]
  7. Kwa M, Veenstra J, Roos M, 1993. Molecular characterization of beta-tubulin genes present in benzimidazole-resistant populations of Haemonchus contortus. Mol Biochem Parasitol 60: 133–144. [Google Scholar]
  8. Lubega G, Prichard R, 1990. Specific interactions of benzimidazole anthelmintics with tubulin: high affinity binding and benzimidazole resistance in Haemonchus contortus. Mol Biochem Parasitol 38: 221–232. [Google Scholar]
  9. Dent JA, Smith MM, Vassilatis DK, Avery L, 2000. The genetics of ivermectin resistance in Caenorhabditis elegans. Proc Natl Acad Sci U S A 97: 2674–2679. [Google Scholar]
  10. Prichard R, 2001. Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol 17: 445–453. [Google Scholar]
  11. Esterre P, Plichart C, Sechan Y, Nguyen N, 2001 . The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health 6: 190–195. [Google Scholar]
  12. Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Richard-Lenoble D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV, 2000. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 121: S147–S160. [Google Scholar]
  13. Awadzi K, Edwards G, Duke BO, Opoku NO, Attah SK, Addy ET, Ardrey AE, Quartey B, 2003. The co-administration of ivermectin and albendazole: safety, pharmacokinetics and efficacy against Onchocerca volvulus. Ann Trop Med Parasitol 97: 165–178. [Google Scholar]
  14. Shenoy R, Suma T, John A, Arun S, Kumaraswami V, Fleckenstein L, Na-Bangchang K, 2002. The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole. Ann Trop Med Parasitol 96: 603–614. [Google Scholar]
  15. Dreyer G, Amaral F, Noroes J, Medeiros Z, Addiss D, 1995. A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasis. Trans R Soc Trop Med Hyg 89: 225–226. [Google Scholar]
  16. Ismail MM, Jayakody RL, Weil GJ, Fernando D, de Silva MS, de Silva GA, Balasooriya WK, 2001. Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcar-bamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 95: 332–335. [Google Scholar]
  17. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B, Buttner DW, 2000. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355: 1242–1243. [Google Scholar]
  18. Hoerauf A, Adjei O, Buttner D, 2002. Antibiotics for the treatment of onchocerciasis and other filarial infections. Curr Opin Investig Drugs 3: 533–537. [Google Scholar]
  19. Tagboto SK, Townson S, 1996. Onchocerca volvulus and O. lie-nalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo. Ann Trop Med Parasitol 90: 497–505. [Google Scholar]
  20. Beach MJ, Streit TG, Addiss DG, Prospere R, Roberts JM, Lammie PJ, 1999. Assessment of combined ivermectin and al-bendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. Am J Trop Med Hyg 60: 479–486. [Google Scholar]
  21. Dunyo SK, Nkrumah FK, Simonsen PE, 2000. Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Trans R Soc Trop Med Hyg 94: 437–443. [Google Scholar]
  22. Pani S, Subramanyam Reddy G, Das PK, Vanamail P, Hoti S, Ramesh J, Das P, 2002. Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study. Filaria J 1: 1. [Google Scholar]
  23. Eberhard ML, Lammie PJ, Dickinson CM, Roberts JM, 1991. Evidence of nonsusceptibility to diethylcarbamazine in Wuchereria bancrofti. J Infect Dis 163: 1157–1160. [Google Scholar]
  24. Andrade LD, Medeiros Z, Pires ML, Pimentel A, Rocha A, Figueredo-Silva J, Coutinho A, Dreyer G, 1995. Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis. Trans R Soc Trop Med Hyg 89: 319–321. [Google Scholar]
  25. Houston R, 2000. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes. Parasitology 121 (suppl): 161–173. [Google Scholar]
  26. Noroes J, Dreyer G, Santos A, Mendes VG, Medeiros Z, Addiss D, 1997. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg 91: 78–81. [Google Scholar]
  27. Hoerauf A, Mand S, Volkmann L, Buttner M, Marfo-Debrekyei Y, Taylor M, Adjei O, Buttner DW, 2003. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med Microbiol Immunol (Berl) 192: 211–216. [Google Scholar]
  28. Joint Action Forum, Fifth Session, 1999. African Programme for Onchocerciasis Control. Ouagadougou, Burkina Faso, 2.

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error